JPRN-UMIN000030767已完成未知
A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions. - A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions.
Department of Pediatrics, Kanazawa University Hospital0 个研究点目标入组 8 人开始时间: 2018年3月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1months-old 至 192months-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are positive for HBs antigen, HCV antibody, or HIV antibody. 2. Patients with active other malignancies. 3. Women who are pregnant, of childbearing potential, or lactating. 4. Patients who experienced serious hypersensitivity or anaphylaxis to cyclophosphamide. 5. patients who are not eligble for this study at the discretion of the investigator.
研究者
相似试验
招募中
不适用
A study of haploidentical transplantation with post-transplant cyclophosphamideAML,ALL,MDS,NHL,MM,CMJPRN-UMIN000019089Department of Hematology, Kanazawa University Hospital40
已完成
不适用
Haploidentical transplantation with post-transplant cyclophosphamideJPRN-UMIN000018730Division of Hematology & Oncology, Department of Medicine, Kurume University School of Medicine21
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioninghematologic malignanciesJPRN-UMIN000020655JSCT42
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioningJPRN-UMIN000020656JSCT36
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioningJPRN-UMIN000014408JSCT62